<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-14T15:44:38Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/p936543kgw.1" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/p936543kgw.1</identifier>
                <datestamp>2022-04-04T14:53:04Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Montalvo, Raul</dc:creator>
    <dc:title>base anticuerpos neutralizante post vacunados covid-19</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>Lista personal de salud vacunados con dos dosis de  vacuna SINOPHARMA , cuantificación de anticuerpos neutralizantes y anticuerpos IgG.
With the arrival of the COVID-19 vaccine, the decrease in cases of Infection by Coronavirus 19 (COVID-19) was evidenced. The objective of the study was to quantify the production of neutralizing antibodies (Nab) and immunoglobulin G (S-IgG)  in frontline workers immunized with two doses of the BBIBP-CorV/Sinopharma vaccine. A cross-sectional analytical observational study was carried out in health personnel immunized with the inactivated vaccine (BBIBP-CorV). Their plasma samples were collected four months after the second dose. We measured antibody responses (NAb, S-IgG). Of a total of 172 people evaluated, 110 (64%) people had already had COVID-19 before entering the study, NAb titers were greater than 10 AU/mL in 61% of those vaccinated, and 89% showed S-IgG greater than 50 AU/mL. Workers older than 60 years were the group that did not develop enough antibodies. The correlation of NaB and S-IgG was positive (r=0.84) (p&lt;0.001). The administration of two doses of the inactivated BBIBP-CorV/Sinopharma vaccine caused a remarkable Nab and S-IgG response, except in those over 60 years of age.</dc:description>
    <dc:subject>COVID-19</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/p936543kgw.1</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/p936543kgw.1</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/p936543kgw</dc:relation>
    <dc:date>2022-04-04T14:53:04Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
